Author

Dongxu Chen

Xiamen UniversityORCID 0000-0002-4357-2653Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Dongxu Chen2 papers · Peking University

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Bin LaniD· 1 shared Chen‐Song ZhangiD· 1 shared Fangfang CheniD· 1 shared Fuqing Chen· 1 shared Haili ChengiD· 1 shared Hong Wen· 1 shared Hui-Hui HuiD· 1 shared Jianfeng WuiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Bin LanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

AMPK acts to remove immune barriers to CD8+ T cell-mediated immunity against hepatocellular carcinoma

Hui-Hui Hu, Xuefeng Wang, Bin Lan, Haili Cheng, Hong Wen, Fangfang Chen, Jianfeng Wu, Mengqi Li, Jiazhou Chen, Jinhui Zhang, Dongxu Chen, Shiyu Lin, Jieyu Lin, Mingyang Yang, Zhenhua Wu, , Sheng‐Cai Lin

This study shows that aldometanib activates AMPK to enhance CD8+ T cell infiltration and control hepatocellular carcinoma growth in immune-competent mice.

Cell Research · Nov 25, 2025Peer-reviewedImmunology